top of page
GUIDELINE FOR DEPRESCRIBING OPIOID ANALGESICS
Guideline Development Group
Our multidisciplinary guideline development group consists of 17 members.
The group is comprised of:
-
Healthcare professionals with experience in caring for persons taking opioids (general practitioners, pain specialists, addiction specialists, registered nurses, pharmacists, physiotherapists) .
-
Researchers with expertise in pain management and/or deprescribing in Australia and internationally.
-
Methodologists with expertise in deprescribing guideline development, conducting systematic reviews, and the GRADE approach.
-
Implementation experts.
-
Organisational representative.
-
Consumer representative.
Table 1: Guideline development group members, affiliations and roles
Name | Organisational affiliation(s) | Discipline/role/expertise |
|---|---|---|
Ms Rawa Osman | NPS MedicineWise, Sydney, Australia | Organisational Representative,
Pharmacist |
Dr Jonathan Penm | Sydney Pharmacy School, Faculty of Medicine and Health, The University of Sydney, Sydney, Australia | Pharmacist,
Content Expert |
Dr Emily Reeve | Quality Use of Medicines and Pharmacy Research Centre, Clinical and Health Sciences, University of South Australia, Adelaide, Australia | Pharmacist,
Deprescribing Expert,
Deprescribing Guidelines Expert |
Dr Sharon Reid | Royal Australian College of General Practitioners.
Specialty of Addiction Medicine, Central Clinical School, Faculty of Medicine and Health, University of Sydney, Sydney, Australia
Drug Health Services, Sydney Local Health District, Sydney, Australia. | General Practitioner, Addiction Medicine |
Dr Janney Wale |
Independent consumer representative | Community Engagement |
Page 1 of 1
bottom of page